10x Genomics Inc - Ordinary Shares - Class A
TXG
Market Cap$2.1B
Close$
$42.06
88% upside
Current Fair Value
88% upsideUndervalued by 88% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.10 Billion |
|---|---|
| Enterprise Value | $1.83 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.24 |
| Beta | 1.92 |
| Outstanding Shares | 105,651,593 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.96 |
|---|---|
| PEG | 20.27 |
| Price to Sales | 4.47 |
| Price to Book Ratio | 3.73 |
| Enterprise Value to Revenue | 2.9 |
| Enterprise Value to EBIT | -7.91 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About 10x Genomics Inc
CEO: Serge Saxonov